MIRA Pharmaceuticals, Inc. Common Stock Financial Flexibility Index
MIRA Pharmaceuticals, Inc. Common Stock financial flexibility index. MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a Financial Flexibility Index of -29.53x as of June 2026. Free cash flow of $-1.21 Million (operating CF $-1.21 Million minus capex $3.00) represents -30% of total liabilities ($40.82K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MIRA Pharmaceuticals, Inc. Common Stock (2020–2025)
Financial flexibility index of MIRA Pharmaceuticals, Inc. Common Stock from 2020 to 2025. Historical Financial Flexibility Index trend for MIRA Pharmaceuticals, Inc. Common Stock across 6 annual periods. Check MIRA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
MIRA Pharmaceuticals, Inc. Common Stock Financial Flexibility Index by Year (2020–2025)
MIRA Pharmaceuticals, Inc. Common Stock financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for MIRA Pharmaceuticals, Inc. Common Stock. For the full cash flow conversion analysis, see cash flow conversion of MIRA Pharmaceuticals, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.64x | $-4.66 Million | $-4.66 Million | $702.07K | ▲ +13.6% |
| 2024 | -7.69x | $-5.56 Million | $-5.56 Million | $723.35K | ▲ +5.3% |
| 2023 | -8.12x | $-4.53 Million | $-4.53 Million | $558.10K | ▼ -110.7% |
| 2022 | -3.85x | $-5.60 Million | $-5.60 Million | $1.45 Million | ▼ -206.3% |
| 2021 | -1.26x | $-1.38 Million | $-1.38 Million | $1.09 Million | ▼ -67.2% |
| 2020 | -0.75x | $-67.99K | $-67.99K | $90.36K | — |